{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:30:13Z","timestamp":1787923813919,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006438","name":"Office of the Assistant Secretary for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.msard.2026.107356","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:44:31Z","timestamp":1782715471000},"page":"107356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum angiogenesis-hypoxia biomarkers in relapsing-remitting multiple sclerosis"],"prefix":"10.1016","volume":"113","author":[{"given":"Heather Y.F.","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Batty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mankarman","family":"Ghuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Camara-Lemarroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107356_bib0001","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-031-14190-4_15","article-title":"Non-invasive detection of persistent cortical hypoxia in multiple sclerosis using frequency domain near-infrared spectroscopy (fdNIRS)","volume":"1395","author":"Adingupu","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.msard.2026.107356_bib0002","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1471-4159.2006.04221.x","article-title":"The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis","volume":"99","author":"Dello Russo","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2026.107356_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X261418928","article-title":"Remyelination and its association with increased oxygen extraction fraction in acute multiple sclerosis lesions","author":"Elanghovan","year":"2026","journal-title":"J. Cereb Blood Flow Metab."},{"key":"10.1016\/j.msard.2026.107356_bib0004","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2013.04.013","article-title":"Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis","volume":"261","author":"Fagone","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107356_bib0005","first-page":"11","article-title":"Angiogenesis and multiple sclerosis pathogenesis: a glance at new pharmaceutical approaches","author":"Gentile","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.msard.2026.107356_bib0006","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1093\/brain\/awaa255","article-title":"Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships","volume":"143","author":"Geraldes","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107356_bib0007","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","article-title":"Ageing and multiple sclerosis","volume":"22","author":"Graves","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107356_bib0008","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10517-024-06219-4","article-title":"Neural and glial regulation of angiogenesis in CNS in ischemic stroke","volume":"177","author":"Grinchevskaya","year":"2024","journal-title":"Bull Exp. Biol. Med."},{"key":"10.1016\/j.msard.2026.107356_bib0009","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1084\/jem.20101974","article-title":"Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice","volume":"209","author":"Han","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2026.107356_bib0010","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3389\/fimmu.2017.01810","article-title":"Gene expression profiling of multiple sclerosis pathology identifies early patterns of demyelination surrounding chronic active lesions","volume":"8","author":"Hendrickx","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.msard.2026.107356_bib0011","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00401-023-02627-4","article-title":"Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis","volume":"146","author":"Hofmann","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2026.107356_bib0012","first-page":"15","article-title":"Hypoxic neuroinflammation in the pathogenesis of multiple sclerosis","author":"Hollingworth","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.msard.2026.107356_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2022.109671","article-title":"Texture analysis in brain T2 and diffusion MRI differentiates histology-verified grey and white matter pathology types in multiple sclerosis","volume":"379","author":"Hosseinpour","year":"2022","journal-title":"J. Neurosci. Method."},{"key":"10.1016\/j.msard.2026.107356_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1213377","article-title":"Distinct characteristics and severity of brain magnetic resonance imaging lesions in women and men with multiple sclerosis assessed using verified texture analysis measures","volume":"14","author":"Hosseinpour","year":"2023","journal-title":"Front Neurol."},{"key":"10.1016\/j.msard.2026.107356_bib0015","article-title":"Human disease-specific cell signatures in non-lesional tissue in multiple sclerosis detected by single-cell and spatial transcriptomics","author":"Lam","year":"2023","journal-title":"BioRxiv"},{"key":"10.1016\/j.msard.2026.107356_bib0016","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-510X(02)00421-5","article-title":"Hypoxia-like tissue injury as a component of multiple sclerosis lesions","volume":"206","author":"Lassmann","year":"2003","journal-title":"J. Neurol Sci."},{"key":"10.1016\/j.msard.2026.107356_bib0017","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrn3550","article-title":"Pathophysiology of the brain extracellular matrix: a new target for remyelination","volume":"14","author":"Lau","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.msard.2026.107356_bib0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","volume":"21","author":"Lee","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.msard.2026.107356_bib0019","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/s41593-024-01796-z","article-title":"Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions","volume":"27","author":"Lerma-Martin","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.msard.2026.107356_bib0020","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/brain\/aww173","article-title":"Defining secondary progressive multiple sclerosis","volume":"139","author":"Lorscheider","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107356_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2024.11.016","article-title":"SnRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses","volume":"113","author":"Macnair","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.msard.2026.107356_bib0022","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/acn3.51215","article-title":"Levels of brain-derived neurotrophic factor in patients with multiple sclerosis","volume":"7","author":"Naegelin","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107356_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2022.944908","article-title":"Advanced diffusion MRI and image texture analysis detect widespread brain structural differences between relapsing-remitting and secondary progressive multiple sclerosis","volume":"16","author":"Oladosu","year":"2022","journal-title":"Front Hum. Neurosci."},{"key":"10.1016\/j.msard.2026.107356_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2025.110562","article-title":"Advanced brain diffusion MRI and image texture measures have the potential to predict multi-domain functional outcomes in multiple sclerosis","volume":"424","author":"Oladosu","year":"2025","journal-title":"J. Neurosci. Method."},{"key":"10.1016\/j.msard.2026.107356_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pneurobio.2018.06.008","article-title":"The sinister face of heme oxygenase-1 in brain aging and disease","volume":"172","author":"Schipper","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.msard.2026.107356_bib0026","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/s41593-024-01746-9","article-title":"VEGF-A-mediated venous endothelial cell proliferation results in neoangiogenesis during neuroinflammation","volume":"27","author":"Shahriar","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.msard.2026.107356_bib0027","doi-asserted-by":"crossref","first-page":"11668","DOI":"10.3390\/cimb46100693","article-title":"Exploring the gene expression and plasma protein levels of HSP90, HSP60, and GDNF in multiple sclerosis patients and healthy controls","volume":"46","author":"Sokolowski","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.msard.2026.107356_bib0028","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11940-024-00816-4","article-title":"A hypoxia-inflammation cycle and multiple sclerosis: mechanisms and therapeutic implications","volume":"27","author":"Soroush","year":"2025","journal-title":"Curr. Treat Option. Neurol."},{"key":"10.1016\/j.msard.2026.107356_bib0029","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41569-018-0030-z","article-title":"Endothelial dysfunction and angiogenesis impairment in the ageing vasculature","volume":"15","author":"Ungvari","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.msard.2026.107356_bib0030","article-title":"Serum heme oxygenase-1 level predicts clinical outcome after acute ischemic stroke","volume":"30","author":"Wang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.msard.2026.107356_bib0031","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/acn3.52150","article-title":"Investigating cortical hypoxia in multiple sclerosis via time-domain near-infrared spectroscopy","volume":"11","author":"Williams","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107356_bib0032","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1007\/s10072-024-07463-2","article-title":"The changes of oxygen extraction fraction in different types of lesions in relapsing-remitting multiple sclerosis: a cross-sectional and longitudinal study","volume":"45","author":"Xie","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107356_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110791","article-title":"Lysyl oxidases: emerging biomarkers and therapeutic targets for various diseases","volume":"131","author":"Yang","year":"2020","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.msard.2026.107356_bib0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200477","article-title":"Angiogenesis and hypoxia biomarkers in progressive multiple sclerosis","volume":"12","author":"Yong","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"10.1016\/j.msard.2026.107356_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1595929","article-title":"Progression independent of relapsing biology in multiple sclerosis: a real-word study","volume":"16","author":"Yong","year":"2025","journal-title":"Front Neurol."},{"key":"10.1016\/j.msard.2026.107356_bib0036","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41582-021-00581-x","article-title":"Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis","volume":"18","author":"Yong","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107356_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105525","article-title":"Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: a randomized controlled pilot clinical trial of domperidone add-on treatment","volume":"85","author":"Zhang","year":"2024","journal-title":"Mult. Scler. Relat. Disord"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:50:59Z","timestamp":1787921459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S2211034826003925"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107356","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum angiogenesis-hypoxia biomarkers in relapsing-remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107356"}}